Sec Form 4 Filing - BALLARD RAND A @ MEDASSETS INC - 2013-07-16

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
BALLARD RAND A
2. Issuer Name and Ticker or Trading Symbol
MEDASSETS INC [ MDAS]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Chief Customer Officer
(Last) (First) (Middle)
100 NORTH POINT CENTER EAST, SUITE 200
3. Date of Earliest Transaction (MM/DD/YY)
07/16/2013
(Street)
ALPHARETTA, GA30022
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/16/2013 M 15,082 A $ 15.95 85,787 D
Common Stock 07/16/2013 S 13,163 ( 1 ) D $ 20 ( 2 ) 72,624 D
Common Stock 07/16/2013 M 11,618 A $ 0 84,242 D
Restricted Stock 12,920 ( 3 ) D
Restricted Stock 19,380 ( 4 ) D
Restricted Stock 19,380 ( 4 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $ 15.95 07/16/2013 M 15,082 ( 5 ) 03/25/2018 Common Stock 15,082 $ 0 0 D
Stock-Settled Stock Appreciation Rights $ 14.74 07/16/2013 M 66,124 ( 6 ) 01/05/2016 Common Stock 66,124 $ 0 22,042 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
BALLARD RAND A
100 NORTH POINT CENTER EAST
SUITE 200
ALPHARETTA, GA30022
X Chief Customer Officer
Signatures
/s/ Christopher K. Logsdon, Attorney-In-Fact 07/17/2013
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2012.
( 2 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.03, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
( 3 )The reporting person was granted these service-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016.
( 4 )The reporting person was granted these performance-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016 based on the achievement of certain Company financial performance targets for fiscal year 2013.
( 5 )The reporting person was granted these stock options on March 25, 2008 and are fully vested.
( 6 )The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 5, 2009 and are fully vested.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.